Welcome to our dedicated page for Dassault Systemes news (Ticker: DASTY), a resource for investors and traders seeking the latest updates and insights on Dassault Systemes stock.
DASSAULT SYSTEMES SA ADR (DASTY) news on Stock Titan reflects the official communications of Dassault Systèmes, a software publisher in the information sector whose underlying shares trade on Euronext Paris as DSY.PA. The company’s releases provide insight into its 3DEXPERIENCE platform, virtual worlds strategy and AI-embedded software offerings, as well as its capital markets activity.
Investors following DASTY can use this page to review earnings and financial updates, where Dassault Systèmes reports quarterly and year-to-date revenue, software revenue, recurring revenue, operating margin and diluted earnings per share under IFRS and non-IFRS measures. These announcements also break down software revenue by geography, product line and industry, and highlight the contribution of areas such as Industrial Innovation, Life Sciences and Mainstream Innovation.
The news feed also includes corporate and strategic announcements, such as information about Medidata, a Dassault Systèmes brand that provides clinical trial solutions. Releases describe Medidata Patient, Data and Study Experiences and collaborations with life sciences companies like Sanofi, emphasizing goals such as streamlining clinical workflows, enhancing data quality and accelerating the development of new therapies.
In addition, Dassault Systèmes publishes regulatory and capital markets disclosures, including declarations of the number of outstanding shares and voting rights, reports on trading in its own shares under repurchase programs, and half-year statements on its liquidity contract. Bookmark this page to access a consolidated view of these official updates related to DASTY and the underlying Dassault Systèmes shares.
Dassault Systèmes (DASTY) reported Q4 2025 total revenue up 1% to €1.68B and FY25 total revenue up 4% to €6.24B. FY25 non-IFRS operating margin was 32.0% and non-IFRS diluted EPS was €1.31. ARR reached €4.50B, up 6% year-over-year. The company initiated 2026 non-IFRS guidance: revenue growth 3–5%, operating margin 32.2–32.6%, and diluted EPS €1.30–€1.34. Management highlighted subscription and Cloud momentum, Industrial AI initiatives, and a strategic partnership with NVIDIA.
Dassault Systèmes (DASTY) declared its total number of outstanding shares and voting rights as of January 31, 2026. The company reported 1,341,809,943 outstanding shares and 2,013,517,837 voting rights. Shareholders are directed to declaration rules under AMF articles and contact Investor Relations for threshold notifications.
Dassault Systèmes (DASTY) published the half-year statement for its liquidity contract with Oddo BHF SCA as of December 31, 2025. The liquidity account held 925,197 shares and €5,384,754.01 in cash on that date. The contract was implemented on January 7, 2015 and amended with cash contributions on October 26, 2017 (+€5,000,000) and December 13, 2018 (+€5,000,000). At the June 18, 2019 implementation of the new contract the account showed 62,557 shares and €17,496,140.38 in cash. From July 1, 2025 to December 31, 2025 the liquidity activity comprised 20,126 purchases and 22,371 sales, with volumes of 4,863,746 shares bought (€128,747,093) and 4,796,309 shares sold (€128,114,812.54).
Dassault Systèmes (Ticker: DASTY) reported the total number of outstanding shares and voting rights as of December 31, 2025. The company stated 1,341,806,268 outstanding shares and 2,013,578,477 voting rights.
The release notes that the voting-rights total is calculated on the basis of all outstanding shares, including those whose voting rights are suspended, pursuant to Article 223-11 of the General Regulation of the Autorité des marchés financiers. Shareholders are directed to the investor relations contact for threshold-declaration procedures.
Dassault Systèmes (OTC:DASTY) announced the total number of outstanding shares and voting rights as of November 30, 2025. The company reported 1,341,782,567 outstanding shares and 2,013,594,540 voting rights.
The release notes that voting rights are calculated on the basis of all outstanding shares, including those with suspended voting rights, under Article 223-11 of the Autorité des marchés financiers General Regulation. Shareholders are invited to consult the referenced article for thresholds and to send declarations about threshold crossings to the Investor Relations Service or via Investors@3ds.com.
Dassault Systèmes (DASTY) declared the total number of outstanding shares and voting rights as of October 31, 2025. The company reported 1,341,772,015 outstanding shares and 2,013,588,275 voting rights. The voting-rights total is calculated on the basis of all outstanding shares, including those with suspended voting rights, under Article 223-11 of the AMF General Regulation.
The company reminded shareholders of threshold-declaration rules under Articles 223-16 and 221-3 and provided contact details for the Investor Relations Service for notifications and questions.
Dassault Systèmes (OTC:DASTY) announced that its Medidata brand has extended a 10-plus-year collaboration with Sanofi to support clinical research and speed therapy development. Sanofi will use Medidata Patient, Data, and Study Experiences, including AI-embedded, platform-based solutions and decentralized trial capabilities, with Medidata supplying consulting and end-to-end operational support. The extension aims to unify clinical workflows, reduce silos, and shorten delays to accelerate new therapies and improve patient journeys.
Dassault Systèmes (DASTY) reported a solid Q3 2025 with total revenue up 5% to €1.46B, recurring revenue up 9% and subscription revenue up 16%. 3DEXPERIENCE software revenue rose 16% and 3DEXPERIENCE Cloud grew strongly. Non-IFRS operating margin reached 30.1% (up 100 bps) and non-IFRS diluted EPS was €0.29 (up 10% in constant currency). The group adjusted FY25 revenue growth to 4–6% (from 6–8%) while reaffirming a non-IFRS diluted EPS target of +7–10%. Cash flow and balance-sheet items include €1.33B cash from operations YTD and €3.91B cash and equivalents as of Sept 30, 2025.
Dassault Systèmes (OTC:DASTY) announced on Oct. 23, 2025 an expansion of its 10-plus-year collaboration between Medidata and Sanofi to accelerate clinical research and improve the patient journey.
The new enterprise agreement will deploy Medidata Experiences—patient, data, and study solutions with AI-embedded workflows—to streamline operations, improve data quality, support decentralized clinical trials, and provide strategic consulting and end-to-end operational support to Sanofi.
The expanded partnership aims to reduce silos, cut delays and costs, and speed therapies to market by combining Medidata platform capabilities with Sanofi’s clinical expertise.
Dassault Systèmes (DASTY) declared its total number of outstanding shares and voting rights as of September 30, 2025. The company reported 1,341,653,585 outstanding shares and 2,013,496,529 voting rights.
The total voting rights figure is calculated on the basis of all outstanding shares, including those with suspended voting rights, pursuant to Article 223-11 of the AMF General Regulation. Shareholders are invited to consult the referenced AMF article for threshold declaration rules and to send threshold-crossing declarations to Dassault Systèmes Investor Relations at the provided postal and email addresses.
FAQ
What is the current stock price of Dassault Systemes (DASTY)?
What is the market cap of Dassault Systemes (DASTY)?
